Real-Time Post-Market Signal For Enhanced Surveillance

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA Office of Acquisitions and Grants Services

Contract Value

Not provided

Codes & Classification
Solicitation Number

ODT-2026-133586

NAICS

541519 - Other Computer Related Services

Classification Code

-

Additional Details
Set Aside

NONE

Place of Performance

Silver Spring, Maryland, UNITED STATES

SourceSAM
Documents3
The U.S. Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Sources Sought notice titled "Real-Time Post-Market Signal For Enhanced Surveillance" (Procurement Identifier: ODT-2026-133586). This notice is part of the FDA’s ongoing market research to assess industry capabilities in providing real-time or near-real-time signals that can enhance the agency’s post-market surveillance of regulated products. The primary objective of this market research is to identify commercial organizations that currently offer, or have the potential to offer, timely signal or alert services related to events impacting FDA-regulated products. These events may include, but are not limited to, safety incidents, product quality concerns, supply chain disruptions, and other significant public health signals. The FDA is particularly interested in understanding the availability of such capabilities in the marketplace, the technical approaches that could facilitate integration with FDA systems, and the range of cost models that may be associated with delivering real-time signal feeds. This Request for Information (RFI) is strictly for market research purposes and does not represent a solicitation for proposals or a commitment by the government to issue a solicitation in the future. The information gathered will inform the FDA’s understanding of industry offerings and help shape potential future procurement strategies. The scope of the desired capabilities falls under NAICS Code 541519 (Other Computer Related Services), indicating a focus on advanced IT solutions and data services. There are no set-aside requirements associated with this notice, making it open to all qualified vendors regardless of business size or socioeconomic status. The place of performance for any future activity related to this requirement is Silver Spring, Maryland, USA. The contracting activity is managed by the FDA Office of Acquisitions and Grants Services, a federal office within the Food and Drug Administration. Interested parties are encouraged to review the notice and its attachments, which are available on SAM.gov under Opportunity ID e307355ea01a49d09fe138f20f4ffa31. The notice remains active, with responses due by July 4, 2026, at 14:04. For further information or to submit a response, potential respondents may contact Steven Gagnon ([email protected]) or Philip Frame ([email protected]). Contractors with expertise in real-time data analytics, signal detection, and integration of alerting systems for regulated products are encouraged to respond, as the FDA seeks to better understand the landscape of available solutions and industry best practices for enhanced post-market surveillance.